{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:40:01Z","timestamp":1792730401572,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.hoc.2009.08.009","type":"journal-article","created":{"date-parts":[[2009,11,21]],"date-time":"2009-11-21T06:51:15Z","timestamp":1258786275000},"page":"1275-1297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Infectious Causes of Chronic Immune Thrombocytopenia"],"prefix":"10.1016","volume":"23","author":[{"given":"Roberto","family":"Stasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenella","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel S.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Gordon-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH07-08-0513","article-title":"Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management","volume":"99","author":"Stasi","year":"2008","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcl.2008.01.009","article-title":"Childhood immune thrombocytopenic purpura: diagnosis and management","volume":"55","author":"Blanchette","year":"2008","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MOH.0b013e3282ab9904","article-title":"Secondary immune thrombocytopenic purpura","volume":"14","author":"Liebman","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2893.1996.tb00084.x","article-title":"Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection","volume":"3","author":"Nguyen","year":"1996","journal-title":"J Viral Hepat"},{"issue":"5 Suppl 1","key":"10.1016\/j.hoc.2009.08.009_bib7","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.hoc.2009.08.009_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.smj.0000182873.62872.22","article-title":"Extrahepatic manifestations of hepatitis C","volume":"98","author":"Palekar","year":"2005","journal-title":"South Med\u00a0J"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11894-001-0044-1","article-title":"Extrahepatic manifestations of chronic viral hepatitis","volume":"3","author":"Pyrsopoulos","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"issue":"10","key":"10.1016\/j.hoc.2009.08.009_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cld.2005.07.007","article-title":"Management of the hematologic complications of hepatitis C therapy","volume":"9","author":"Sulkowski","year":"2005","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.hoc.2009.08.009_bib12","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1111\/j.1572-0241.2000.02325.x","article-title":"Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease","volume":"95","author":"Bashour","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0168-8278(95)80027-1","article-title":"Hepatitis C virus infection and autoimmune thrombocytopenic purpura","volume":"23","author":"Pawlotsky","year":"1995","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1996.7542376.x","article-title":"High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders","volume":"95","author":"Pivetti","year":"1996","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2141.2000.02132.x","article-title":"HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy","volume":"110","author":"Garcia-Suarez","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0609.2002.00509.x","article-title":"Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection","volume":"68","author":"Sakuraya","year":"2002","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-0609.2003.00032.x","article-title":"Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center","volume":"70","author":"Zhang","year":"2003","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib19","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80021-3","article-title":"Thrombocytopenia associated with hepatitis C viral infection","volume":"24","author":"Nagamine","year":"1996","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinternmed.2008.576","article-title":"Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection","volume":"169","author":"Chiao","year":"2009","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia","volume":"45","author":"Aster","year":"1966","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0168-8278(97)80291-7","article-title":"Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?","volume":"27","author":"Peck-Radosavljevic","year":"1997","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.44.5.754","article-title":"Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation","volume":"44","author":"Goulis","year":"1999","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2005.00524.x","article-title":"Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia","volume":"75","author":"Iga","year":"2005","journal-title":"Eur J Haematol"},{"issue":"Suppl D","key":"10.1016\/j.hoc.2009.08.009_bib26","first-page":"60D","article-title":"Thrombocytopenia in liver disease","volume":"14","author":"Peck-Radosavljevic","year":"2000","journal-title":"Can J Gastroenterol"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib27","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.V98.8.2293","article-title":"The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines","volume":"98","author":"Hamaia","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.08.009_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00277-004-0844-0","article-title":"Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study","volume":"83","author":"de Almeida","year":"2004","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/jhep.2003.50209","article-title":"A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis","volume":"37","author":"Kajihara","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1386-6346(02)00010-4","article-title":"Mechanisms for increment of platelet associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease","volume":"24","author":"Doi","year":"2002","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2888.x","article-title":"Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia","volume":"77","author":"Panzer","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hoc.2009.08.009_bib32","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2008-09-181073","article-title":"Role of molecular mimicry of hepatitis C-virus (HCV) protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000040842","article-title":"Autoimmune thrombocytopenia associated with hepatitis C virus infection","volume":"99","author":"Hernandez","year":"1998","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200303000-00003","article-title":"Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases","volume":"82","author":"Ramos-Casals","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajh.1180","article-title":"Treatment of hepatitis C related thrombocytopenia with interferon alpha","volume":"68","author":"Rajan","year":"2001","journal-title":"Am J Hematol"},{"issue":"22","key":"10.1016\/j.hoc.2009.08.009_bib36","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.hoc.2009.08.009_bib37","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"issue":"6 Pt 1","key":"10.1016\/j.hoc.2009.08.009_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-96-6-714","article-title":"Autoimmune thrombocytopenic purpura in homosexual men","volume":"96","author":"Morris","year":"1982","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJM198302243080808","article-title":"Coincident classic hemophilia and \u201cidiopathic\u201d thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII)","volume":"308","author":"Ratnoff","year":"1983","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.hoc.2009.08.009_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM198409063111004","article-title":"On the mechanism of thrombocytopenic purpura in sexually active homosexual men","volume":"311","author":"Walsh","year":"1984","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-103-4-542","article-title":"Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome","volume":"103","author":"Walsh","year":"1985","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/08916930410001705448","article-title":"Autoimmune thrombocytopenias","volume":"37","author":"Karpatkin","year":"2004","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2141.1987.tb06920.x","article-title":"Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection","volume":"66","author":"Murphy","year":"1987","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-107-4-474","article-title":"Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study","volume":"107","author":"Kaslow","year":"1987","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/aid.1990.6.261","article-title":"Prevalence, clinical, and laboratory features of thrombocytopenia among HIV-infected individuals","volume":"6","author":"Rossi","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00002030-199104000-00004","article-title":"Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study","volume":"5","author":"Peltier","year":"1991","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.1992.tb06476.x","article-title":"Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men","volume":"82","author":"Mientjes","year":"1992","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0609.1992.tb00591.x","article-title":"Epidemiology of thrombocytopenia in HIV infection","volume":"48","author":"Sloand","year":"1992","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00042560-199704010-00011","article-title":"Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project","volume":"14","author":"Sullivan","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"1 Suppl 2","key":"10.1016\/j.hoc.2009.08.009_bib50","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1053\/j.seminhematol.2008.12.006","article-title":"Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias","volume":"46","author":"Stasi","year":"2009","journal-title":"Semin Hematol"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/09537100120093956","article-title":"Thrombocytopenia in HIV-infected drug users in the HAART era","volume":"12","author":"Burbano","year":"2001","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002030-199001000-00004","article-title":"HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation","volume":"4","author":"Landonio","year":"1990","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.hoc.2009.08.009_bib53","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/00002030-199910010-00014","article-title":"Impaired liver function and retroviral activity are risk factors contributing to HIV-associated thrombocytopenia. Swiss HIV Cohort Study","volume":"13","author":"Ciernik","year":"1999","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/clinids\/17.1.117","article-title":"Hepatitis C virus infection in patients infected with the human immunodeficiency virus","volume":"17","author":"Quan","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jmv.1890420106","article-title":"Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort)","volume":"42","author":"Quaranta","year":"1994","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib56","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/01.qai.0000134759.01684.27","article-title":"Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study","volume":"37","author":"Berhane","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib57","first-page":"405","article-title":"Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study","volume":"166","author":"Levine","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.hoc.2009.08.009_bib58","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood.V91.9.3239","article-title":"Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients","volume":"91","author":"Cole","year":"1998","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.hoc.2009.08.009_bib59","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJM199212173272503","article-title":"Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection","volume":"327","author":"Ballem","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib60","first-page":"398","article-title":"HIV-related thrombocytopenia: four different clinical subsets","volume":"77","author":"Landonio","year":"1992","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib61","first-page":"415","article-title":"The mechanism of thrombocytopenia in patients with HIV infection","volume":"123","author":"Najean","year":"1994","journal-title":"J Lab Clin Med"},{"issue":"24","key":"10.1016\/j.hoc.2009.08.009_bib62","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1073\/pnas.85.24.9763","article-title":"Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts","volume":"85","author":"Karpatkin","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V80.1.162.162","article-title":"Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura","volume":"80","author":"Bettaieb","year":"1992","journal-title":"Blood"},{"issue":"8882","key":"10.1016\/j.hoc.2009.08.009_bib64","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0140-6736(93)92363-X","article-title":"Common epitope on HIV p24 and human platelets","volume":"342","author":"Hohmann","year":"1993","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.hoc.2009.08.009_bib65","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1073\/pnas.94.14.7589","article-title":"GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia","volume":"94","author":"Nardi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib66","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.92.6.2263","article-title":"Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients","volume":"92","author":"Karpatkin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2005-01-0243","article-title":"Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(01)00477-9","article-title":"Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia","volume":"106","author":"Nardi","year":"2001","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib69","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1074\/jbc.M705902200","article-title":"Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.hoc.2009.08.009_bib70","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2004-01-0386","article-title":"Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia","volume":"104","author":"Koefoed","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib71","first-page":"1295","article-title":"Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1)","volume":"134","author":"Zucker-Franklin","year":"1989","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2009.08.009_bib72","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1182\/blood.V75.10.1920.1920","article-title":"Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets","volume":"75","author":"Zucker-Franklin","year":"1990","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V77.3.481.481","article-title":"Human immunodeficiency virus infection of megakaryocytic cells","volume":"77","author":"Sakaguchi","year":"1991","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2009.08.009_bib74","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V81.12.3336.3336","article-title":"Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells","volume":"81","author":"Kunzi","year":"1993","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.hoc.2009.08.009_bib75","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10428190009148861","article-title":"HIV infection of megakaryocytic cell lines","volume":"36","author":"Sato","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/157016206775197646","article-title":"Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression","volume":"4","author":"Sundell","year":"2006","journal-title":"Curr HIV Res"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2141.1999.01169.x","article-title":"Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets","volume":"104","author":"Kowalska","year":"1999","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.hoc.2009.08.009_bib78","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1073\/pnas.86.14.5595","article-title":"Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA","volume":"86","author":"Zucker-Franklin","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib79","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V90.5.1787","article-title":"Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma","volume":"90","author":"Bahner","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib80","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood.V91.5.1479","article-title":"The influence of human immunodeficiency virus-1 on hematopoiesis","volume":"91","author":"Moses","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib81","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V75.6.1267.1267","article-title":"Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs","volume":"75","author":"Ragni","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib82","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0609.1990.tb00422.x","article-title":"Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: implications for therapeutic strategies","volume":"45","author":"Finazzi","year":"1990","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib83","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gut.42.3.338","article-title":"Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan","volume":"42","author":"Maeda","year":"1998","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00042560-200111010-00003","article-title":"HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy","volume":"28","author":"Servais","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00002030-199302000-00008","article-title":"Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia","volume":"7","author":"Landonio","year":"1993","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib86","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-110-5-365","article-title":"Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection","volume":"110","author":"Oksenhendler","year":"1989","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0609.1993.tb00068.x","article-title":"Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication","volume":"50","author":"Cinque","year":"1993","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00000441-200008000-00010","article-title":"Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia","volume":"320","author":"Aboulafia","year":"2000","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/jinf.2001.0833","article-title":"Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors","volume":"42","author":"Carbonara","year":"2001","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib90","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00042560-200206010-00017","article-title":"Limited impact of highly active antiretroviral therapy in thrombocytopenia","volume":"30","author":"Miguez","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.hoc.2009.08.009_bib91","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V80.12.2969.2969","article-title":"Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease","volume":"80","author":"Schacter","year":"1992","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib92","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1096-8652(199706)55:2<118::AID-AJH13>3.0.CO;2-A","article-title":"Successful treatment of HIV-1-related, zidovudine resistant, thrombocytopenia with didanosine","volume":"55","author":"Nasti","year":"1997","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib93","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-121-6-199409150-00005","article-title":"Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial","volume":"121","author":"Marroni","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00042560-199501000-00007","article-title":"Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura","volume":"8","author":"Northfelt","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib95","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1987.tb01333.x","article-title":"Response to therapy in 37 patients with HIV-related thrombocytopenic purpura","volume":"66","author":"Oksenhendler","year":"1987","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib96","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib97","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajh.2830400309","article-title":"Role of splenectomy in the management of hemophilic patients with human immunodeficiency virus-associated immunopathic thrombocytopenic purpura","volume":"40","author":"Leissinger","year":"1992","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V82.1.29.bloodjournal82129","article-title":"Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia","volume":"82","author":"Oksenhendler","year":"1993","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2009.08.009_bib99","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1097\/00002030-200007280-00027","article-title":"Splenic irradiation versus splenectomy for severe, refractory HIV-related thrombocytopenia: effects on platelet counts and immunological status","volume":"14","author":"Marroni","year":"2000","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2009.08.009_bib100","first-page":"707a","article-title":"Correction of thrombocytopenia and ineffective platelet production in patients infected with human immunodeficiency virus (HIV) by PEG-rHuMGDF therapy","volume":"92","author":"Harker","year":"1998","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.hoc.2009.08.009_bib101","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"issue":"9131","key":"10.1016\/j.hoc.2009.08.009_bib102","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib103","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1365-2141.2001.03194.x","article-title":"Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura","volume":"115","author":"Jarque","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib104","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2141.2002.03612.x","article-title":"Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura","volume":"118","author":"Kohda","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00277-002-0579-8","article-title":"Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura","volume":"82","author":"Hino","year":"2003","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib106","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF02983220","article-title":"Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori","volume":"77","author":"Hashino","year":"2003","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib107","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02983780","article-title":"Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review","volume":"77","author":"Ando","year":"2003","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib108","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood-2003-03-0900","article-title":"Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?","volume":"103","author":"Michel","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2141.2003.04735.x","article-title":"Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura","volume":"124","author":"Takahashi","year":"2004","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.hoc.2009.08.009_bib110","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/archinte.164.17.1904","article-title":"Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura","volume":"164","author":"Sato","year":"2004","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib111","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1083-4389.2004.00261.x","article-title":"Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Ando","year":"2004","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib112","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2004.00220.x","article-title":"The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura","volume":"72","author":"Nomura","year":"2004","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib113","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09537100400028685","article-title":"Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment","volume":"16","author":"Veneri","year":"2005","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib114","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2362.2005.01471.x","article-title":"Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan","volume":"35","author":"Inaba","year":"2005","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.amjmed.2004.09.014","article-title":"Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura","volume":"118","author":"Stasi","year":"2005","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib116","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1532\/IJH97.04146","article-title":"Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan","volume":"81","author":"Fujimura","year":"2005","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib117","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","article-title":"Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial","volume":"100","author":"Suzuki","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09537100500462487","article-title":"Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura","volume":"17","author":"Suvajdzic","year":"2006","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000093648","article-title":"The efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura\u2014the first study in Turkey","volume":"116","author":"Sayan","year":"2006","journal-title":"Acta Haematol"},{"issue":"10","key":"10.1016\/j.hoc.2009.08.009_bib120","first-page":"1436","article-title":"Effects of a Helicobacter pylori eradication regimen on antiplatelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura","volume":"91","author":"Asahi","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1523-5378.2007.00477.x","article-title":"Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura","volume":"12","author":"Kodama","year":"2007","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib122","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1523-5378.2007.00502.x","article-title":"Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America","volume":"12","author":"Campuzano-Maya","year":"2007","journal-title":"Helicobacter"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib123","first-page":"112","article-title":"Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico","volume":"59","author":"Estrada-Gomez","year":"2007","journal-title":"Rev Invest Clin"},{"issue":"12","key":"10.1016\/j.hoc.2009.08.009_bib124","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1111\/j.1440-1746.2007.04845.x","article-title":"The long-term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura","volume":"22","author":"Satake","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.hoc.2009.08.009_bib125","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1182\/blood-2006-12-063222","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles","volume":"110","author":"Emilia","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12185-008-0138-8","article-title":"Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura","volume":"88","author":"Jackson","year":"2008","journal-title":"Int J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2009.08.009_bib127","first-page":"S1","article-title":"Helicobacter pylori infection in Japan: current status and future options","volume":"6","author":"Graham","year":"1994","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00042737-199908000-00010","article-title":"Determinants of Helicobacter pylori seroprevalence among Italian blood donors","volume":"11","author":"Russo","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.hoc.2009.08.009_bib129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-140-9-200405040-00028","article-title":"Helicobacter pylori and idiopathic thrombocytopenic purpura","volume":"140","author":"Franceschi","year":"2004","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.44.3.336","article-title":"Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates","volume":"44","author":"Maeda","year":"1999","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12185-008-0247-4","article-title":"Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura","volume":"89","author":"Bai","year":"2009","journal-title":"Int J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2009.08.009_bib132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1523-5378.7.s1.3.x","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"7","author":"Gerhard","year":"2002","journal-title":"Helicobacter"},{"issue":"11","key":"10.1016\/j.hoc.2009.08.009_bib133","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1182\/blood-2006-12-062695","article-title":"Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets","volume":"109","author":"Semple","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib134","first-page":"2939","article-title":"Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients","volume":"118","author":"Asahi","year":"2008","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.hoc.2009.08.009_bib135","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0016-5085(03)00397-4","article-title":"Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation","volume":"124","author":"Byrne","year":"2003","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.hoc.2009.08.009_bib136","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2007-08-105411","article-title":"ITP: time to \u201cbug off\u201d?","volume":"110","author":"Cines","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2009.08.009_bib137","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib138","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10875-007-9111-1","article-title":"Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura","volume":"27","author":"Guo","year":"2007","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.hoc.2009.08.009_bib139","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood-2003-11-3886","article-title":"Helicobacter pylori and ITP: many questions, few answers","volume":"103","author":"McCrae","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jac\/dkm195","article-title":"Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Franchini","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib141","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijgo.2005.01.021","article-title":"Helicobacter pylori infection and platelet counts during pregnancy","volume":"89","author":"Fukui","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.hoc.2009.08.009_bib142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000092343","article-title":"Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts","volume":"116","author":"Ahn","year":"2006","journal-title":"Acta Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib143","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.08.009_bib144","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00277-008-0667-5","article-title":"Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study","volume":"88","author":"Tsumoto","year":"2009","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib145","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2004.05068.x","article-title":"Immune thrombocytopenic purpura: investigation of the role of cytomegalovirus infection","volume":"126","author":"Levy","year":"2004","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib146","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10245330500093658","article-title":"Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult effectively treated with intravenous immunoglobulin: a case report and review","volume":"10","author":"Alliot","year":"2005","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.hoc.2009.08.009_bib147","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood.V95.2.487","article-title":"In vitro infection of megakaryocytes and their precursors by human cytomegalovirus","volume":"95","author":"Crapnell","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2009.08.009_bib148","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00007890-199911150-00016","article-title":"Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection","volume":"68","author":"Toyoda","year":"1999","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.hoc.2009.08.009_bib149","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2141.2005.05522.x","article-title":"Imported malaria is a major cause of thrombocytopenia in children presenting to the emergency department in east London","volume":"129","author":"Ladhani","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib150","first-page":"505","article-title":"Thrombocytopenia\u2014an indicator of acute vivax malaria","volume":"49","author":"Kumar","year":"2006","journal-title":"Indian J Pathol Microbiol"},{"issue":"6","key":"10.1016\/j.hoc.2009.08.009_bib151","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/09537100701194871","article-title":"Depression of platelet counts in apparently healthy children with asymptomatic malaria infection in a Nigerian metropolitan city","volume":"18","author":"Jeremiah","year":"2007","journal-title":"Platelets"},{"key":"10.1016\/j.hoc.2009.08.009_bib152","first-page":"615","article-title":"Thrombocytopenia in malaria\u2013correlation with type and severity of malaria","volume":"52","author":"Jadhav","year":"2004","journal-title":"J Assoc Physicians India"},{"issue":"4","key":"10.1016\/j.hoc.2009.08.009_bib153","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/519844","article-title":"Thrombocytopenia and release of activated von Willebrand factor during early Plasmodium falciparum malaria","volume":"196","author":"de Mast","year":"2007","journal-title":"J\u00a0Infect Dis"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:53:15Z","timestamp":1760183595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858809001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":153,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0889858809001701"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2009.08.009","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious Causes of Chronic Immune Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2009.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}